John W. Kozarich, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 934 shares at $125.00 ($117K) on 2025-07-10, disclosed to the SEC on 2025-07-11.
Scheduled sale ($117k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| LGND | SELL | 2026-03-04 | $179K | — | Filing → |
| LGND | SELL | 2026-02-04 | $175K | — | Filing → |
| LGND | SELL | 2026-01-06 | $173K | — | Filing → |